Igor Chernukhin
Impact in
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- RNA modifications and cancer
- Cancer-related gene regulation
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- Genomics and Chromatin Dynamics 14
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- Genetics 14
- Genetic Syndromes and Imprinting 7
- Estrogen and related hormone effects 4
- Co-authors
- Elena Klenova (19 shared papers)Victor V. Lobanenkov (8 shared papers)Dawn Farrar (12 shared papers)Jason S. Carroll (11 shared papers)France Docquier (11 shared papers)Rolf Ohlsson (4 shared papers)Rituparna Mukhopadhyay (3 shared papers)Joanne Whitehead (3 shared papers)
- Journals
- Cancer Research (4 papers)Cell Reports (3 papers)Breast Cancer Research (3 papers)Molecular and Cellular Biology (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Igor Chernukhin
44 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 1.4k
- Oncology 393
- Genetics 358
- Cancer Research 165
- Immunology 184
Countries citing papers authored by Igor Chernukhin
This map shows the geographic impact of Igor Chernukhin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Chernukhin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Chernukhin more than expected).
Fields of papers citing papers by Igor Chernukhin
This network shows the impact of papers produced by Igor Chernukhin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Chernukhin. The network helps show where Igor Chernukhin may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Chernukhin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 234 | |
| 2 | 2007 | 137 | |
| 3 | 2018 | 128 | |
| 4 | 2016 | 111 | |
| 5 | 2004 | 110 | |
| 6 | 2001 | 88 | |
| 7 | 2000 | 85 | |
| 8 | 2005 | 83 | |
| 9 | 2008 | 81 | |
| 10 | 2008 | 78 | |
| 11 | 2006 | 71 | |
| 12 | 2009 | 70 | |
| 13 | 2005 | 56 | |
| 14 | 2018 | 50 | |
| 15 | 2018 | 49 | |
| 16 | 2019 | 43 | |
| 17 | 2006 | 39 | |
| 18 | 2009 | 36 | |
| 19 | 1999 | 33 | |
| 20 | 2014 | 26 |
About Igor Chernukhin
Igor Chernukhin is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Infectious Diseases, having authored 44 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (14 papers), Epigenetics and DNA Methylation (9 papers), Genetic Syndromes and Imprinting (7 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (5 papers), Cancer-related Molecular Pathways (4 papers), Estrogen and related hormone effects (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Oncology (393 citations), Genetics (358 citations), Cancer Research (165 citations) and Immunology (184 citations). Igor Chernukhin has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Elena Klenova, Victor V. Lobanenkov, Dawn Farrar, Jason S. Carroll, France Docquier, Rolf Ohlsson, Rituparna Mukhopadhyay, Joanne Whitehead, Wenqiang Yu and M. Dolores Delgado. Their work appears in journals such as Cancer Research, Cell Reports, Breast Cancer Research, Molecular and Cellular Biology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.